MMRC partnership with MDS Pharma

MDS Pharma Services, a leading provider of innovative drug discovery and development solutions, has been selected as the preferred contract research organization (CRO) of the Multiple Myeloma Research Consortium (MMRC). MDS Pharma Services will manage multiple MMRC pre-clinical and clinical research efforts, including data management related to the MMRC's tissue collection program.